Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $185.90 | N/A |
Market Cap | $2.36B | N/A |
Shares Outstanding | 12.69M | N/A |
Employees | 2.23K | N/A |